Metraipolis › archive › dc_1368e5fc2d8f

Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential — Europe PMC PMID:42794958

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794958
DOI
10.3390/cancers18182992
License (as archived)
solo-consultazione
Archived
2026-10-09T22:40:17.964Z
SHA-256 of the archived text
4a388a0508f614e1d4daaa0798ad5cfa9d4498ceeb752bd9f37a1574912eab54
Stable URL of this page
https://metraipolis.com/documento/dc_1368e5fc2d8f

How to cite

Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential — Europe PMC PMID:42794958 — Europe PMC (en), https://europepmc.org/article/MED/42794958 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1368e5fc2d8f (Metraipolis archive dc_1368e5fc2d8f, sha256 4a388a0508f614e1d4daaa0798ad5cfa9d4498ceeb752bd9f37a1574912eab54)
BibTeX
@misc{dc1368e5fc2d8f,
  title = {Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential — Europe PMC PMID:42794958},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794958},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1368e5fc2d8f; sha256 4a388a0508f614e1d4daaa0798ad5cfa9d4498ceeb752bd9f37a1574912eab54},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794958. Agents can read the archived copy with the MCP tool read_document.